SEOUL, South Korea, April 21, 2025 /PRNewswire/ -- DAAN Biotherapeutics, a leading innovative drug development company specializing in T-Cell receptor (TCR)-based therapies, has signed an exclusive licensing agreement with GC Cell, a gene and cell therapy firm, for the tumor...
Read More Details
Finally We wish PressBee provided you with enough information of ( DAAN Biotherapeutics and GC Cell Sign Exclusive Technology Transfer Agreement for Tumor Antigen-Specific Antibody Sequence to Advance CAR-T and CAR-NK Cell Therapies )
Also on site :
- 'Golden Bachelor' Mel Owens Issues Bold Statement About Upcoming Season
- European militarization robbing taxpayers – Lavrov
- Tobey Maguire's 'Spider-Man' Trilogy Returns to Theaters With Rare Extended Cut